TrialPloS one2015

Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial.

Ting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.